OCCLUSIONs & INFECTIONS
  Do not forget about the relationship between Occlusions and CRBSIs
 

The process to treat occlusions often involves significant manipulation of the catheter site to administer anti-clotting agents. This increased manipulation exposes the site and access port to additional contamination.

In order to dislodge or lyse a thrombus, typically one needs to instill saline, heparin or antithrombolytic agents repeatedly. The increased incidence of manipulation of CVAD increases the potential for introduction of infectious agents, so any reduction in the need to gain access to the CVAD line may have a positive effect on infection control.”1

Intraluminal occlusions provide a rich culture medium for bacteria to grow. “Blood clearance from catheters is an essential part of catheter maintenance as the presence of thrombus is a well documented as correlative to CRBSI.”2 Efforts should always be directed at prevention of catheter occlusions and bacterial ingress to minimize biofilm formation.

   
 

 

References:

1. Lenhart, C. RN et al. Prevention vs. Treatment of VAD Occlusions. Journal of Vascular Access Devices JVAD.

2. Ryder, Marcia. Research coordinator USC Center for Medical Bioform Research, IV therapy.net

   
   
   
Product
Seal of Trust
Fewer BSI's
Fewer Occlusions
Myth: Neutral pressure
Order a displacement Kit
Displacement Video
Occlusions & Infections
Studies, White Papers
Regulations
History of Connectors
 
 
 
Customer News
PR announcements
 
more >>
 
 
The MaxPlus Needleless Connector
The MaxPlus is the fastest growing needleless connector on the market today. As evidence to its success the MaxPlus is being utilized in a number of facilities who in 2006 were awarded Honor Roll status by the U.S. News and World Report as 'America's Best Hospitals." The nation's top facilities are using the MaxPlus for two main reasons; it significantly lowers Catheter Related Blood Stream infections CRBSIs and catheter line occlusions. Reducing these two complications improves patient outcomes.
more details >>
 
 
 
2007 Medegen, Inc. , all rights reserved.
MaxPlus and Maximus are registered trademarks of Medegen, Inc.